111 related articles for article (PubMed ID: 1099159)
21. Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers.
Mansell PW; Litwin MS; Ichinose H; Krementz ET
Cancer Res; 1975 May; 35(5):1288-94. PubMed ID: 1120313
[TBL] [Abstract][Full Text] [Related]
22. Palmar and plantar pustulosis elicited by Candida antigen.
Uehara M
Arch Dermatol; 1978 May; 114(5):730-1. PubMed ID: 348116
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy for accessible tumors utilizing delayed hypersensitivity reactions and separated components of the immune system.
Klein E; Holtermann O; Milgrom H; Case RW; Klein D; Rosner D; Djerassi I
Med Clin North Am; 1976 May; 60(3):389-418. PubMed ID: 1271886
[TBL] [Abstract][Full Text] [Related]
24. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
25. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
[TBL] [Abstract][Full Text] [Related]
26. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
27. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
28. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
[TBL] [Abstract][Full Text] [Related]
29. Delayed-type hypersensitivity skin testing. A review.
Ahmed AR; Blose DA
Arch Dermatol; 1983 Nov; 119(11):934-45. PubMed ID: 6639116
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
[TBL] [Abstract][Full Text] [Related]
31. Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides.
Cen P; Duvic M; Cohen PR; Kurzrock R
J Am Acad Dermatol; 2008 Mar; 58(3):382-6. PubMed ID: 18280334
[TBL] [Abstract][Full Text] [Related]
32. Delayed-type hypersensitivity reactions to nominal protein antigens and to environmental allergens: similarities and differences.
Tsicopoulos A; Fahy O; Tonnel AB
Eur J Dermatol; 1999 Jun; 9(4):261-8. PubMed ID: 10356401
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
34. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
[TBL] [Abstract][Full Text] [Related]
35. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
[TBL] [Abstract][Full Text] [Related]
36. Malignant lymphoma, reticulum cell type. Ultrastructural and cytological demonstration of Lutzner cells.
Petrozzi JW; Raque CJ; Goldschmidt H
Arch Dermatol; 1971 Jul; 104(1):38-44. PubMed ID: 4941073
[No Abstract] [Full Text] [Related]
37. Responses of neoplasms to local immunotherapy.
Klein E; Holtermann OA; Case RW; Milgrom H; Rosner D; Adler S
Am J Clin Pathol; 1974 Aug; 62(2):281-9. PubMed ID: 4602090
[No Abstract] [Full Text] [Related]
38. Mycosis fungoides d'embleé: CD30-negative cutaneous large T-cell lymphoma.
O'quinn RP; Zic JA; Boyd AS
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):861-3. PubMed ID: 11050596
[TBL] [Abstract][Full Text] [Related]
39. [Complex therapy of certain forms of hemodermia].
Smelov NS; Kalamkarian AA
Vrach Delo; 1967 Mar; 3():111-2. PubMed ID: 4890656
[No Abstract] [Full Text] [Related]
40. Anti-Ia-reactive cells in mycosis fungoides: a study of skin biopsies, single epidermal cells and circulating T lymphocytes.
Tjernlund UM; Scheynius A; Kabelitz D; Klareskog L
Acta Derm Venereol; 1981; 61(4):291-301. PubMed ID: 6173983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
